KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Long-Term Investments (2016 - 2025)

Historic Long-Term Investments for Jazz Pharmaceuticals (JAZZ) over the last 11 years, with Q3 2025 value amounting to $720.0 million.

  • Jazz Pharmaceuticals' Long-Term Investments rose 8000.0% to $720.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $720.0 million, marking a year-over-year increase of 8000.0%. This contributed to the annual value of $580.0 million for FY2024, which is 38333.33% up from last year.
  • According to the latest figures from Q3 2025, Jazz Pharmaceuticals' Long-Term Investments is $720.0 million, which was up 8000.0% from $480.0 million recorded in Q2 2025.
  • Jazz Pharmaceuticals' Long-Term Investments' 5-year high stood at $720.0 million during Q3 2025, with a 5-year trough of $60.0 million in Q2 2022.
  • Over the past 5 years, Jazz Pharmaceuticals' median Long-Term Investments value was $375.0 million (recorded in 2024), while the average stood at $368.8 million.
  • As far as peak fluctuations go, Jazz Pharmaceuticals' Long-Term Investments surged by 68125.0% in 2024, and later crashed by 2320.0% in 2025.
  • Jazz Pharmaceuticals' Long-Term Investments (Quarter) stood at $335.0 million in 2021, then plummeted by 82.09% to $60.0 million in 2022, then surged by 100.0% to $120.0 million in 2023, then soared by 383.33% to $580.0 million in 2024, then grew by 24.14% to $720.0 million in 2025.
  • Its Long-Term Investments was $720.0 million in Q3 2025, compared to $480.0 million in Q2 2025 and $710.0 million in Q1 2025.